Riverhead, NYNCT07399587Now EnrollingIRB Ready

Heart Failure NYHA Class III Clinical Trial in Riverhead, NY

Access cutting-edge heart failure nyha class iii treatment through this clinical trial at a research site in Riverhead. Study-provided care at no cost to qualified participants.

Sponsored by Northwell Health

Quick Self-Assessment

See if you qualify for this Riverhead location

Preparing your pre-screening questions…

Expert Care in Riverhead

Access heart failure nyha class iii specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related heart failure nyha class iii treatment provided free

Apply for This Riverhead Location

Check if you qualify for this heart failure nyha class iii clinical trial in Riverhead, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Riverhead

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Riverhead site if eligible
  4. 4Begin participation

About This Heart Failure NYHA Class III Study in Riverhead

The goal of this study is to utilize CardioMems (measurement of pulmonary artery diastolic pressure) to assess BaroStim. At the time of CardioMems insertion, patients will be screened for candidacy to receive a BaroStim device. Patients will be followed for 3 months after the CardioMems insertion before undergoing insertion of a Barostim. Patients who have undergone a CardioMems, will be eligible for enrollment after 3 months of medication management and optimization. Patients will be followed for 1 year after insertion of Barostim.

Sponsor: Northwell Health

Who Can Participate

Inclusion Criteria

Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Male or female, ages 18-80 years
Diagnosed with NYHA Class III Heart Failure with LVEF\<35%
Able to tolerate oral medications for guideline directed medical therapy titration period
Have undergone insertion of CardioMems and BaroStim devices per standard of care.
It is a standard of care to recommend that females of reproductive potential use highly effective contraception, because of the teratogenic potential of many medications used to treat HFrEF. In addition, withdrawal of GDMT during pregnancy may reverse the positive remodeling and lead to life threatening worsening of heart failure. Women of child-bearing age need to agree to use such a method during study participation and indefinitely after the end of the study.

Exclusion Criteria

Individuals ineligible for either CardioMems or BaroStim devices.
NT-proBNP \>1600 mg/dL
Indicated for CRT-D device (left bundle branch block)
Initial 6-minute walk test distance less than 140 m
Left ventricular assist device (LVAD)
History of carotid vascular procedure (carotid endarterectomy)
Pregnancy or lactation
Known allergic reactions to components of the BaroStim or CardioMems insertion or guideline directed medical therapy for heart failure
Febrile illness within 30 days of study enrollment
Treatment with another investigational drug or other intervention within 1 year
Current smoker or tobacco use within 1 year
Enrolled in any other CVRx funded study, including investigator-initiated research, registries, or other pre- or post-market studies.
Vulnerable individuals as outlined below

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Riverhead?

Yes, this clinical trial (NCT07399587) has an active research site in Riverhead, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Heart Failure NYHA Class III Treatment Options in Riverhead, NY

If you're searching for heart failure nyha class iii treatment options in Riverhead, NY, this clinical trial (NCT07399587) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Riverhead research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart failure nyha class iii specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all heart failure nyha class iii clinical trials near you to find additional studies recruiting in your area.

More Heart Failure Trials in Riverhead, NY

See all heart failure clinical trials recruiting in Riverhead — not just this study.

Browse Heart Failure Trials in Riverhead →

Browse More Trials by Condition

Heart Failure TrialsAnkylosing Spondylitis TrialsFanconi Anemia TrialsAll Conditions →

Ready to Join in Riverhead?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Riverhead, NY